These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder. Calkin CV Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713 [TBL] [Abstract][Full Text] [Related]
3. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319 [TBL] [Abstract][Full Text] [Related]
4. Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature. Serafini G; Pardini M; Monacelli F; Orso B; Girtler N; Brugnolo A; Amore M; Nobili F; Team On Dementia Of The Irccs Ospedale Policlinico San Martino DM Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33672401 [TBL] [Abstract][Full Text] [Related]
6. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE. Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450 [TBL] [Abstract][Full Text] [Related]
7. Bipolar depression: a major unsolved challenge. Baldessarini RJ; Vázquez GH; Tondo L Int J Bipolar Disord; 2020 Jan; 8(1):1. PubMed ID: 31903509 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Romeo B; Choucha W; Fossati P; Rotge JY Psychiatry Res; 2015 Dec; 230(2):682-8. PubMed ID: 26548981 [TBL] [Abstract][Full Text] [Related]
9. Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder. Calkin C; McClelland C; Cairns K; Kamintsky L; Friedman A Front Psychiatry; 2021; 12():636174. PubMed ID: 34113269 [TBL] [Abstract][Full Text] [Related]
10. Areas of controversy in neuroprogression in bipolar disorder. Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559 [TBL] [Abstract][Full Text] [Related]
12. Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior. Chan LF; Eu CL; Soh SY; Maniam T; Shahidii Kadir Z; Chong BTW; Loo JL; Sharip S; Wong VCW; Loo TH; Ng YP; Kahn DA J Psychiatr Pract; 2018 Jul; 24(4):279-291. PubMed ID: 30427812 [TBL] [Abstract][Full Text] [Related]
13. Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Kishimoto T; Chawla JM; Hagi K; Zarate CA; Kane JM; Bauer M; Correll CU Psychol Med; 2016 May; 46(7):1459-72. PubMed ID: 26867988 [TBL] [Abstract][Full Text] [Related]
15. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146 [TBL] [Abstract][Full Text] [Related]
17. An update on ketamine and its two enantiomers as rapid-acting antidepressants. Zhang K; Hashimoto K Expert Rev Neurother; 2019 Jan; 19(1):83-92. PubMed ID: 30513009 [No Abstract] [Full Text] [Related]
18. Neuroprogression and illness trajectories in bipolar disorder. Kapczinski NS; Mwangi B; Cassidy RM; Librenza-Garcia D; Bermudez MB; Kauer-Sant'anna M; Kapczinski F; Passos IC Expert Rev Neurother; 2017 Mar; 17(3):277-285. PubMed ID: 27659841 [TBL] [Abstract][Full Text] [Related]
19. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ketamine in bipolar depression: A systematic review. Alberich S; Martínez-Cengotitabengoa M; López P; Zorrilla I; Núñez N; Vieta E; González-Pinto A Rev Psiquiatr Salud Ment; 2017; 10(2):104-112. PubMed ID: 27387226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]